Locations
San Diego, CA, USA
industry
Biotechnology · DeepTech · Information Technology
Size
11-50 employees
Stage
Series A
founded in
2021
CRISPR QC is pioneering advancements in gene editing through its CRISPR Analytics Platform™, which provides real-time insights into RNP formation, DNA target binding, and cleavage activity. This platform enables researchers to optimize their CRISPR workflows by offering direct measurements of nucleic acid-protein interactions, thus enhancing the efficiency and accuracy of gene editing processes. By addressing common challenges in CRISPR experiments, CRISPR QC helps to reduce costs and timelines associated with genetic research, positioning itself as a leader in the biotechnology sector focused on CRISPR technology.
Something looks off?